BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
August 09, 2021 07:00 ET
|
BioNTech SE
More than one billion doses of BNT162b2 vaccine supplied to more than 100 countries or territories worldwide as of July 21, 2021Signed agreements for approximately 2.2 billion doses of BNT162b2 in...
BioNTech veröffentlicht am 9. August 2021 Ergebnisse des zweiten Quartals sowie Informationen zum operativen Fortschritt
August 02, 2021 07:00 ET
|
BioNTech SE
MAINZ, Deutschland, 2. August 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 9. August 2021, die Ergebnisse des zweiten Quartals 2021...
BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021
August 02, 2021 07:00 ET
|
BioNTech SE
Mainz, Germany, August 2, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter on Monday, August 9th, 2021....
Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference
March 04, 2021 08:30 ET
|
Entera Bio Ltd.
BOSTON and JERUSALEM, March 04, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its...
Cognition Therapeutics to Present Corporate and Clinical Update at H.C. Wainwright Global Life Sciences Conference
March 03, 2021 08:01 ET
|
Cognition Therapeutics, Inc.
New York, NY, March 03, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually
January 06, 2021 16:30 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
BioNTech präsentiert auf der 39. Annual J.P. Morgan Healthcare Conference
January 05, 2021 06:00 ET
|
BioNTech SE
MAINZ, Deutschland, 5. Januar 2021 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, dass CEO und Mitgründer Prof. Dr. Ugur Sahin das Unternehmen...
BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 06:00 ET
|
BioNTech SE
MAINZ, GERMANY, January 5, 2021 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview...
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
November 02, 2020 16:05 ET
|
Entera Bio Ltd.
BOSTON and JERUSALEM, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its...
Adevinta ASA (ADE) - Adevinta reports further recovery in Q3
October 27, 2020 02:01 ET
|
Adevinta ASA
Agreement to acquire eBay Classifieds Group Improving trends confirmed EBITDA margin exceptionally high, driven by cost saving initiatives, delayed expenses and positive one-offs Significant...